Nasdaq Viri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq viri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Viri Today - Breaking & Trending Today

Virios Therapeutics, Inc. (NASDAQ:VIRI) Short Interest Down 42.7% in October

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 111,000 shares, a decrease of 42.7% from the October 15th total of 193,800 shares. Based on an average daily volume of 599,200 shares, the short-interest ratio […] ....

Gregory Scott Duncan , Virios Therapeutics Inc , Renaissance Technologies , Vanguard Group Inc , Virios Therapeutics Company Profile , Envestnet Asset Management Inc , Virios Therapeutics , Get Free Report , Scott Duncan , Street Corp , Envestnet Asset Management , Asset Management , Virios Therapeutics Daily , Nasdaq Viri ,

McCollum Christoferson Group LLC Makes New Investment in Virios Therapeutics, Inc. (NASDAQ:VIRI)

McCollum Christoferson Group LLC acquired a new stake in Virios Therapeutics, Inc. (NASDAQ:VIRI – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,700 shares of the company’s stock, valued at approximately $42,000. A number of other hedge funds […] ....

Gregory Scott Duncan , Renaissance Technologies , Mccollum Christoferson Group , Exchange Commission , Vanguard Group Inc , Virios Therapeutics Inc , Susquehanna International Group , Envestnet Asset Management Inc , Virios Therapeutics Company Profile , Securities Exchange Commission , Virios Therapeutics , Free Report , International Group , Asset Management , Get Free Report , Scott Duncan , Visit Holdingschannel , Virios Therapeutics Daily , Nasdaq Viri , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Virios Therapeutics, Inc. (NASDAQ:VIRI) Short Interest Down 33.4% in September

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 278,500 shares, a decline of 33.4% from the September 15th total of 418,400 shares. Based on an average daily volume of 546,700 shares, […] ....

Gregory Scott Duncan , Geode Capital Management , Virios Therapeutics Inc , Vanguard Group Inc , Mccollum Christoferson Group , Renaissance Technologies , Virios Therapeutics , Get Free Report , Scott Duncan , Collum Christoferson Group , Capital Management , Street Corp , Virios Therapeutics Daily , Nasdaq Viri ,